Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
NanoBio® Corporation is a privately-held biopharmaceutical company focused on developing and commercializing anti-infective products and mucosal vaccines derived from its patented NanoStatÔ technology platform. The company’s lead product candidates for the treatment of Herpes labialis (cold sores) and onychomycosis (nail fungus) are in clinical trials. In addition, preclinical work is ongoing for a treatment for methicillin resistant Staphylococcus aureus (MRSA), and mucosal vaccines for influenza and Hepatitis B. The company’s headquarters and laboratory facilities are located in Ann Arbor, Michigan. ( www.nanobio.com )
NanoBio Corporation
2311 Green Road Suite A
Ann Arbor, Michigan 48105
USA
Tel: (734) 302-4000